[1]
|
Wu, Q., Nie, D.Y., Ba-Alawi, W., et al. (2022) PRMT Inhibition Induces a Viral Mimicry Response in Triple-Negative Breast Cancer. Nature Chemical Biology, 18, 821-830. https://doi.org/10.1038/s41589-022-01024-4
|
[2]
|
Huang, Z., He, A., Wang, J., et al. (2022) Toll-Like Receptor 3 Is a Potential Prognosis Marker and Associated with Immune Infiltration in Stomach Adenocarcinoma. Cancer Biomarkers, 34, 77-93. https://doi.org/10.3233/CBM-210354
|
[3]
|
Afroz, R., Tanvir, E, M., Tania, M., et al. (2022) LPS/TLR4 Pathways in Breast Cancer: Insights into Cell Signalling. Current Medicinal Chemistry, 29, 2274-2289. https://doi.org/10.2174/0929867328666210811145043
|
[4]
|
Escudero-Lourdes, C., Alvarado-Morales, I. and Tokar, E.J. (2022) Stem Cells as Target for Prostate Cancer Therapy: Opportunities and Challenges. Stem Cell Reviews and Reports, 18, 2833-2851. https://doi.org/10.1007/s12015-022-10437-6
|
[5]
|
Tan, C., Wei, Y., Ding, X., et al. (2022) Cell Senescence-Associated Genes Predict the Malignant Characteristics of Glioblastoma. Cancer Cell International, 22, Article No. 411. https://doi.org/10.1186/s12935-022-02834-1
|
[6]
|
Bareche, Y., Buisseret, L., Gruosso, T., et al. (2020) Unraveling Triple-Negative Breast Cancer Tumor Microenvironment Heterogeneity: Towards an Optimized Treatment Approach. JNCI: Journal of the National Cancer Institute, 112, 708-719. https://doi.org/10.1093/jnci/djz208
|
[7]
|
Le Naour, J., Liu, P., Zhao, L., et al. (2021) A TLR3 Ligand Reestablishes Chemotherapeutic Responses in the Context of FPR1 Deficiency. Cancer Discovery, 11, 408-423. https://doi.org/10.1158/2159-8290.CD-20-0465
|
[8]
|
Borovcanin, M.M., Radosavljevic, G.D., Pantic, J., et al. (2021) Contrasting Roles of the Galectin-3 in the Schizophrenia Onset, Clinical Presentation, and Somatic Comorbidity. Current Topics in Medicinal Chemistry, 21, 1471-1487. https://doi.org/10.2174/1568026621666210611162420
|
[9]
|
Qu, Y., Cheng, B., Shao, N., et al. (2020) Prognostic Value of Immune-Related Genes in the Tumor Microenvironment of Lung Adenocarcinoma and Lung Squamous Cell Carcinoma. Aging, 12, 4757-4777. https://doi.org/10.18632/aging.102871
|
[10]
|
Han, S., Yin, X., Wang, Y., et al. (2020) Co-Expression of HIF-1 and TLR3 Is Associated with Poor Prognosis in Oral Squamous Cell Carcinoma. International Journal of Clinical and Experimental Pathology, 13, 65-72.
|
[11]
|
Lin, Y., Liu, S., Bian, L., et al. (2023) Bioinformatics Analysis of Immune Infiltration in Endometrial Carcinoma Tumors and Its Relationship with Prognosis. Cancer Diagnosis & Prognosis, 3, 416-427. https://doi.org/10.21873/cdp.10234
|
[12]
|
Nissen, M.S., Ryding, M., Meyer, M., et al. (2020) Autoimmune Encephalitis: Current Knowledge on Subtypes, Disease Mechanisms and Treatment. CNS & Neurological Disorders-Drug Targets, 19, 584-598. https://doi.org/10.2174/1871527319666200708133103
|
[13]
|
Wang, Z. and Wu, X. (2020) Study and Analysis of Antitumor Resistance Mechanism of PD1/PD-L1 Immune Checkpoint Blocker. Cancer Medicine, 9, 8086-8121. https://doi.org/10.1002/cam4.3410
|
[14]
|
Wawrzyniak, D., Grabowska, M., Głodowicz, P., et al. (2020) Down-Regulation of Tenascin-C Inhibits Breast Cancer Cells Development by Cell Growth, Migration, and Adhesion Impairment. PLOS ONE, 15, e0237889. https://doi.org/10.1371/journal.pone.0237889
|
[15]
|
Feng, W., Wang, Y., Chen, S., et al. (2020) Intra-Tumoral Heterogeneity and Immune Responses Predicts Prognosis of Gastric Cancer. Aging, 12, 24333-24344. https://doi.org/10.18632/aging.202238
|
[16]
|
Le Naour, J., Thierry, S., Scuderi, S.A., et al. (2023) A Chemically Defined TLR3 Agonist with Anticancer Activity. OncoImmunology, 12, Article ID: 2227510. https://doi.org/10.1080/2162402X.2023.2227510
|
[17]
|
Manna, P.R., Ahmed, A.U., Molehin, D., et al. 2022 () Hormonal and Genetic Regulatory Events in Breast Cancer and Its Therapeutics: Importance of the Steroidogenic Acute Regulatory Protein. Biomedicines, 10, Article 1313. https://doi.org/10.3390/biomedicines10061313
|
[18]
|
Tkach, M., Thalmensi, J., Timperi, E., et al. (2022) Extracellular Vesicles from Triple Negative Breast Cancer Promote Pro-Inflammatory Macrophages Associated with Better Clinical Outcome. Proceedings of the National Academy of Sciences of the United States of America, 119, e2107394119. https://doi.org/10.1073/pnas.2107394119
|
[19]
|
Shahverdi, M., Masoumi, J., Ghorbaninezhad, F., et al. (2022) The Modulatory Role of Dendritic Cell-T Cell Cross-Talk in Breast Cancer: Challenges and Prospects. Advances in Medical Sciences, 67, 353-363. https://doi.org/10.1016/j.advms.2022.09.001
|
[20]
|
Dvornikova, K.A., Bystrova, E.Y., Platonova, O.N. and Churilov, L.P. (2020) Polymorphism of Toll-Like Receptor Genes and Autoimmune Endocrine Diseases. Autoimmunity Reviews, 19, Article ID: 102496. https://doi.org/10.1016/j.autrev.2020.102496
|
[21]
|
Zhu, Z., Zhu, X., Yang, S., et al. (2020) Yin-Yang Effect of Tumour Cells in Breast Cancer: From Mechanism of Crosstalk Between Tumour-Associated Macrophages and Cancer-Associated Adipocytes. American Journal of Cancer Research, 10, 383-392.
|
[22]
|
Florez-Alvarez, L., Ruiz-Perez, L., Taborda, N., et al. (2020) Toll-Like Receptors as a Therapeutic Target in Cancer, Infections and Inflammatory Diseases. Immunotherapy, 12, 311-322. https://doi.org/10.2217/imt-2019-0096
|
[23]
|
Liu, W., Zhang, C., Gong, X., et al. (2020) Prognostic Value of Immune-Related Genes in Laryngeal Squamous Cell Carcinoma. Translational Cancer Research, 9, Article 6287. https://doi.org/10.21037/tcr-20-2173
|
[24]
|
Chen, W., Lin, W., Wu, L., et al. (2022) A Novel Prognostic Predictor of Immune Microenvironment and Therapeutic Response in Kidney Renal Clear Cell Carcinoma Based on Necroptosis-Related Gene Signature. International Journal of Medical Sciences, 19, 377-392. https://doi.org/10.7150/ijms.69060
|
[25]
|
Zhu, S., Zhang, T., Zheng, L., et al. (2021) Combination Strategies to Maximize the Benefits of Cancer Immunotherapy. Journal of Hematology & Oncology, 14, Article No. 156. https://doi.org/10.1186/s13045-021-01164-5
|
[26]
|
Li, D. and Wu, M. (2021) Pattern Recognition Receptors in Health and Diseases. Signal Transduction and Targeted Therapy, 6, Article No. 291. https://doi.org/10.1038/s41392-021-00687-0
|
[27]
|
Huang, R., Sun, Z., Xian, S., et al. (2022) The Role of Toll-Like Receptors (TLRs) in Pan-Cancer. Annals of Medicine, 54, 1918-1937. https://doi.org/10.1080/07853890.2022.2095664
|
[28]
|
Sui, Q., Zhang, X., Chen, C., et al. (2022) Inflammation Promotes Resistance to Immune Checkpoint Inhibitors in High Microsatellite Instability Colorectal Cancer. Nature Communications, 13, Article No. 7316. https://doi.org/10.1038/s41467-022-35096-6
|